Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

immunity · Mechanism Report

Do concurrent Anaplasma phagocytophilum MSP5 IgM and IgG reactivity confirm active anaplasmosis?

Concurrent MSP5 IgM and IgG reactivity, a negative blood PCR, and normal MSP2 antibodies do not by themselves confirm active anaplasmosis.

PlausibleOctober 1, 20267 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Your concurrent Anaplasma phagocytophilum MSP5 IgM and IgG reactivity indicates a recent or ongoing immune response, but a negative blood PCR and normal MSP2 antibodies mean it does not by itself confirm active anaplasmosis.

laying out figure…
2 of 5 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes a lab pattern that may suggest immune reactivity, but the conclusion frames it as indirect and timing-dependent rather than diagnostic on its own. It also notes that MSP5 results can be influenced by cross-reactivity, while a negative PCR and normal MSP2 antibodies do not settle whether active infection is present. Confirmation is better supported by paired IgG IFA testing showing a rising titer.

Verified conclusion

In a 77-year-old man, these laboratory results should be interpreted as indirect and timing-dependent evidence rather than as a stand-alone diagnosis of active Anaplasma phagocytophilum infection.

Serology and diagnostic meaning

  • Concurrent MSP5 IgM and IgG reactivity demonstrates antibody reactivity, but does not reliably date infection or establish an ongoing immune response. IgM is unreliable for identifying recent anaplasmosis, while IgG may persist for months to years, occasionally >4 years.
  • MSP5 reactivity may also reflect cross-reactive antibodies. MSP5-based assays can cross-react among Anaplasma species and may not reliably distinguish Anaplasma from Ehrlichia infection.
  • A normal MSP2-associated antibody result likewise neither confirms nor excludes active disease. Early in illness, IgG is often negative; antigenic variation in MSP2/P44 can further complicate target-specific antibody interpretation.
  • The best-supported serologic confirmation is paired A. phagocytophilum IgG IFA testing showing seroconversion or a ≥4-fold rise in titer between acute and convalescent specimens.

PCR interpretation and timing

  • A negative whole-blood PCR does not establish that active anaplasmosis is absent, and therefore cannot resolve the diagnosis by itself. In one prospective evaluation, PCR sensitivity was 74% (specificity 100%).
  • PCR is most sensitive during the first week of illness, particularly days 0–4, and its sensitivity may decline within 48 hours of appropriate antibiotic treatment. Thus, a negative result obtained later in illness or after doxycycline is particularly difficult to interpret.

Clinical implications

  • Results should be integrated with compatible febrile illness, tick exposure, blood-count or liver-test abnormalities, specimen timing, treatment history, and alternative explanations. When clinical suspicion is meaningful, CDC guidance advises not delaying treatment because of an initial negative test.

Bottom line

  • The claim is only partly correct: negative PCR and normal MSP2 antibodies do not independently confirm active anaplasmosis, but concurrent MSP5 IgM/IgG does not reliably demonstrate recent or ongoing infection.

References

  1. Early Recognition And... — cdc.gov ↗
  2. Diagnosis and Management of Tickborne Rickettsial Diseases ... — cdc.gov ↗
  3. Cited In for PMID: 17123248 - Search Results - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  4. Human Granulocytic Anaplasmosis - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  5. Value of PCR, Serology, and Blood Smears for Human ... — pmc.ncbi.nlm.nih.gov ↗
  6. Zurich Open Repository and — zora.uzh.ch ↗
  7. Characterization of Anaplasma phagocytophilum Major ... — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible14 sourcesCan suboptimal vitamin D reduce immune regulation?→Plausible8 sourcesIs food allergy an immune reaction distinct from the TMAO pathway?→